Thank you, Madam Chair, and thank you to all the witnesses for your testimony today.
When we started off the testimony, many of the comments were largely about the failure of the business end and the willingness of venture capital to take on risks. As the conversations evolved, it seems we've come back to the earlier stages in the process. You've actually identified issues even at the basic research part of this process.
Dr. Menon, with respect to this partnership funding for basic research, what are you suggesting might be the solution for that? Obviously, these developments don't get into the hands of venture capitalists. If you have these big companies, they're right at the beginning of the process, claiming ownership.